Clinical Trials Directory

Trials / Unknown

UnknownNCT02457013

Interest of High Flow Nasal Cannula (HFNC) Versus Non Invasive Ventilation During the Initial Management of Severe Bronchiolitis in Infants

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
142 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
1 Day – 6 Months
Healthy volunteers
Not accepted

Summary

1. The purpose of the study is to evaluate prospectively the clinical benefits of High flow nasal canula (HFNC: 2l/kg/min) versus nasal CPAP( continuous positive airway pressure) (n-CPAP: 7 cmH2O) in the initial management of bronchiolitis in infants. 2. Design: non-inferiority study, prospective, controlled, randomized, multi-center. 3. Design: Infants less than 6 month admitted in pediatric intensive care unit for respiratory distress (mWCAS \>3) secondary to bronchiolitis but not requiring mechanical ventilation will be randomized in two groups: "n-CPAP"(nasal continuous positive airway pressure) or "HFNC" during 24 hours. 4. Conditions of measurements: Primary endpoint: Proportion of failure in both arms during the first 24 hours. Failure criteria: A raise of the Clinical score for respiratory distress (mWCAS) (1 point) or respiratory rate (10/min /H0 and above 60/min) or discomfort (EDIN) (1point /H0 and above 4) or apnea. Secondary outcomes: Assessment at H1, H12, H24 of mWCAS, respiratory and heart rate, EDIN score, skin lesions, FiO2 (fraction of inspired oxygen ) required to achieve an oxygen saturation between 94 and 97%, transcutaneous PCO2 (carbon dioxide partial pressure) (correlated to an initial gas analysis), Report SpO2 / FiO2 5. Statistic: Intention to treat Analysis. Expected number of patients: 71 per arm: 142 children. 6. Study Schedule: October 2014-April 2016

Conditions

Interventions

TypeNameDescription
DEVICEHFNCHygh flow nasal canula HFNC
DEVICEnCPAPnasal nCPAP

Timeline

Start date
2014-10-01
Primary completion
2016-04-01
Completion
2016-11-01
First posted
2015-05-29
Last updated
2015-05-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02457013. Inclusion in this directory is not an endorsement.